1. Home
  2. CC vs AVDL Comparison

CC vs AVDL Comparison

Compare CC & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemours Company (The)

CC

Chemours Company (The)

HOLD

Current Price

$16.04

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.55

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CC
AVDL
Founded
2014
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
CC
AVDL
Price
$16.04
$21.55
Analyst Decision
Buy
Buy
Analyst Count
9
8
Target Price
$17.33
$19.14
AVG Volume (30 Days)
2.7M
1.4M
Earning Date
02-17-2026
03-02-2026
Dividend Yield
2.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,837,000,000.00
$248,517,000.00
Revenue This Year
$3.34
$65.47
Revenue Next Year
$4.07
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
0.03
79.88
52 Week Low
$9.13
$6.38
52 Week High
$20.12
$23.57

Technical Indicators

Market Signals
Indicator
CC
AVDL
Relative Strength Index (RSI) 71.72 59.40
Support Level $14.76 $21.45
Resistance Level $16.58 $21.60
Average True Range (ATR) 0.79 0.07
MACD 0.27 -0.03
Stochastic Oscillator 86.84 70.73

Price Performance

Historical Comparison
CC
AVDL

About CC Chemours Company (The)

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: